Panaceutics is the first company to provide the personalized nutrition you want, based on scientific tests, preferences or beliefs, delivered to your door.
About Panaceutics Nutrition
Panaceutics Nutrition was founded in 2018 to provide personalized nutritional products and to capitalize on technology licensed from Panacea Biomatx.
We provide the ability for consumers to choose from over 24 nutritional ingredients to add to a food base, creating a highly personalized nutrition product. These nutritional products can be produced in 2 oz or 4 oz squeezable pouches which provide a daily supply of the macro and micro ingredients consumers desire.
There are at least three differentiators that make us unique in the nutrition space:
1. Our blending and manufacturing technology makes it economical for us to create a mass customized nutrition product and allows us to produce fully customized nutrition products (formulation and labeling) designed for individual needs. This capability is based on technology, automation and robotics created by Panacea and exclusively licensed to Panaceutics Nutrition.
2. Our nutritional products can combine macro and micro ingredients in one serving, something few other companies can do. This is again due to intellectual property from Panacea.
3. The nutritional products can be shipped directly to the consumer in 14 or 28 day packages, with your branding.
Our executive team has extensive experience in food and nutrition, in pharmaceutical science, in automation and robotics, and has extensive entrepreneurial experience.
Andy Schwab – CEO
Andrew (Andy) Schwab is Panaceutics’ CEO. He is a successful entrepreneur with over 25 years’ experience building technology based startup companies. He has been an impactful mentor and advisor to dozens of companies throughout his career, and has served on multiple boards designed to vet technology and executive teams. As a seasoned senior executive with proven management and startup skills, Andy has led two local companies featured in the Triangle Fast 50, which recognizes the 50 fastest-growing, privately-held companies in the Research Triangle area.
Formerly Senior Director at iRobot Corp, and founder of five technology companies with three successful exits and two IPOs, Edison is the Co-Founder and Chief Technology Officer of Panaceutics. He holds 25+ patents and has developed and installed high-speed automation for dozens of Fortune 500 companies. Federal level patent expert witness trial experience. Edison was a Morehead Scholar at UNC, received his MBA from Duke, and received an Engineering Sciences degree from Oxford University.
As Co-founder and Chief Science Officer of Panaceutics, Staton uses his 25 years of experience in biotechnology and pharmaceutical research to help create products for an individual’s health and wellness needs. Staton holds a BS in Biochemistry, MS in Gerontology, and an MBA, and has authored multiple peer-reviewed scientific papers. As a molecular pharmacologist at GlaxoSmithKline, Staton developed both a broad technical expertise and therapeutic expertise while leading multiple drug discovery projects. In addition, Staton spent five years as Director of the Office of Innovation Commercialization at UNC-Greensboro managing and licensing intellectual property, and negotiating complex inter-institutional agreements.
Mark Friedman – VP Finance
As Vice President of Finance and Treasurer, Mark utilizes his 30 years of financial experience to guide the company in relation to its cash management, contract negotiation, and various procurement needs, as well as its Human Resource functions. Mark holds a BBA in AccountingBusiness from the University of Rochester and a MBA from Duke University’s Fuqua School of Business.
Andy Gunn is CEO of StatEraOne in Raleigh and a seasoned executive with over 30 years in the life sciences industry. He is skilled in Clinical Research, Clinical Quality Assurance, Regulatory Affairs (pre and post), Real World Evidence (RWE), GxP, Quality Assurance, Pharmaceutical Microbiology, Quality Control, and Clinical Microbiology. Andy has deep credibility and established relationships with FDA, EMA, MHRA, MHLW, TGA, JCAHO, CAP and other international health authorities. He has a history of building strong organizations focused on ethical behavior, hard work, and delivering results. Andy has a Master’s in Molecular Science from Drexel University College of Medicine, and a bachelors degree in cell science and microbiology from NC State.